Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

[1]  J. Newcomer,et al.  Glucose-induced increase in memory performance in patients with schizophrenia. , 1999, Schizophrenia bulletin.

[2]  T. Hershey,et al.  Short-term and long-term memory in early temporal lobe dysfunction. , 1998, Neuropsychology.

[3]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[4]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[5]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[6]  Y. Sheline,et al.  Memory improvement following induced hyperinsulinemia in alzheimer's disease , 1996, Neurobiology of Aging.

[7]  M. Paule,et al.  Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery , 1995, Pharmacology Biochemistry and Behavior.

[8]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[9]  J. Kleinman,et al.  Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. , 1995, Archives of general psychiatry.

[10]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[11]  D R Medoff,et al.  Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.

[12]  J. Newcomer,et al.  Increased declarative memory performance during controlled hyperglycemia in patients with schizophrenia , 1995, Schizophrenia Research.

[13]  T. Bliss,et al.  Memories of NMDA receptors and LTP , 1995, Trends in Neurosciences.

[14]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.

[15]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.

[16]  D. Kowalska.  Effects of hippocampal lesions on spatial delayed responses in dog , 1995, Hippocampus.

[17]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[18]  Brenda Milner,et al.  Right-hippocampal contralateral-hand effect in the recall of spatial location in the tactual modality , 1994, Neuropsychologia.

[19]  Tyrone D. Cannon,et al.  Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. , 1994, Archives of general psychiatry.

[20]  E. Buffalo,et al.  Acute behavioral effects of MK-801 in rhesus monkeys: Assessment using an operant test battery , 1994, Pharmacology Biochemistry and Behavior.

[21]  P Alvarez,et al.  The animal model of human amnesia: long-term memory impaired and short-term memory intact. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Newcomer,et al.  Glucocorticoid-induced impairment in declarative memory performance in adult humans , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[24]  R. Gur,et al.  Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.

[25]  R Kikinis,et al.  Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. , 1993, The American journal of psychiatry.

[26]  J. Newcomer,et al.  Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. , 1993, Behavioral neuroscience.

[27]  Ronald W. Skelton,et al.  The neuropharmacological and neurochemical basis of place learning in the Morris water maze , 1993, Brain Research Reviews.

[28]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[29]  C. B. Cave,et al.  Intact verbal and nonverbal short‐term memory following damage to the human hippocampus , 1992, Hippocampus.

[30]  R. Morris,et al.  The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  R. Depue,et al.  Facilitation of Working Memory in Humans by a D2 Dopamine Receptor Agonist , 1992, Journal of Cognitive Neuroscience.

[32]  V. Doyère,et al.  Linear relationship between the maintenance of hippocampal long‐term potentiation and retention of an associative memory , 1992, Hippocampus.

[33]  D. Ingram,et al.  NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks , 1991, Pharmacology Biochemistry and Behavior.

[34]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[35]  M. Pontecorvo,et al.  N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. , 1991, Behavioral neuroscience.

[36]  R. Gur,et al.  Neuropsychological function in schizophrenia. Selective impairment in memory and learning. , 1991, Archives of general psychiatry.

[37]  P. E. Gold,et al.  Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory , 1991, Brain Research.

[38]  R. Waziri,et al.  Evidence of glutamatergic deficiency in schizophrenia , 1991, Neuroscience Letters.

[39]  W. Turski,et al.  Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks , 1990, Neuropharmacology.

[40]  H. Tilson,et al.  MK-801 impedes the acquisition of a spatial memory task in rats , 1990, Pharmacology Biochemistry and Behavior.

[41]  R. Morris,et al.  Hippocampal synaptic plasticity and NMDA receptors: a role in information storage? , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  K. Jones,et al.  Differential effects of σ and phencyclidine receptor ligands on learning , 1990 .

[43]  W. Abraham,et al.  Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats , 1990, Pharmacology Biochemistry and Behavior.

[44]  Robert A. Bornstein,et al.  The Wechsler Memory Scale—Revised , 1990 .

[45]  V. Denoble,et al.  Differential effects of sigma and phencyclidine receptor ligands on learning. , 1990, European journal of pharmacology.

[46]  E. Butelman.  A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task , 1989, Pharmacology Biochemistry and Behavior.

[47]  R. Morris.  Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D- aspartate receptor antagonist AP5 , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[49]  D. Reich,et al.  Ketamine: an update on the first twenty-five years of clinical experience , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[50]  S. Deutsch,et al.  A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. , 1989, Clinical neuropharmacology.

[51]  P. Goldman-Rakic,et al.  Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. , 1989, Journal of neurophysiology.

[52]  R. M. Nicol,et al.  The performance of amnesic subjects on tests of experimental amnesia in animals: delayed matching-to-sample and concurrent learning , 1988, Neuropsychologia.

[53]  J. Gruzelier,et al.  Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. , 1988, Archives of general psychiatry.

[54]  E. Costa,et al.  Learning impairment in rats by N-methyl-D-aspartate receptor antagonists , 1988, Neuropharmacology.

[55]  L. Squire,et al.  Human amnesia and animal models of amnesia: performance of amnesic patients on tests designed for the monkey. , 1988, Behavioral neuroscience.

[56]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[57]  J. Olney.  Excitatory Transmitters and Neuropsychiatry Disorders , 1988 .

[58]  G. Handelmann,et al.  Selective memory impairment by phencyclidine in rats. , 1987, European journal of pharmacology.

[59]  J. Mastropaolo,et al.  Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys , 1987, Pharmacology Biochemistry and Behavior.

[60]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[61]  P. Cryer,et al.  External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. , 1985, The Journal of laboratory and clinical medicine.

[62]  L. Squire,et al.  Medial temporal lesions in monkeys impair memory on a variety of tasks sensitive to human amnesia. , 1985, Behavioral neuroscience.

[63]  James V. Hinrichs,et al.  Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.

[64]  C. P. Hughes,et al.  Psychometric differentiation of mild senile dementia of the Alzheimer type. , 1984, Archives of neurology.

[65]  J. M. Moerschbaecher,et al.  Phenycyclidine in combination with d-amphetamine: Differential effects on acquisition and performance of response chains in monkeys , 1984, Pharmacology Biochemistry and Behavior.

[66]  N C Andreasen,et al.  Negative symptoms in schizophrenia , 1982 .

[67]  P. White,et al.  Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.

[68]  D. Lodge,et al.  Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. , 1982, European journal of pharmacology.

[69]  A. Atkinson,et al.  The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980 , 1981 .

[70]  H. H. Kornhuber,et al.  Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.

[71]  R. Erard,et al.  The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? , 1980, Journal of psychedelic drugs.

[72]  R. Zukin,et al.  Specific [3H]phencyclidine binding in rat central nervous system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Lazdunski,et al.  Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Winocur.  Effects of interference on discrimination learning and recall by rats with hippocampal lesions , 1979, Physiology & Behavior.

[75]  N. Butters,et al.  Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. , 1978, Archives of neurology.

[76]  J. Yesavage,et al.  Acute phencyclidine (PCP) intoxication: psychopathology and prognosis. , 1978, The Journal of clinical psychiatry.

[77]  Christie Golden,et al.  Stroop Color and Word Test: Manual for Clinical and Experimental Uses. , 1978 .

[78]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[79]  L. Chait,et al.  The behavioral pharmacology of phencyclidine. , 1976, Clinical toxicology.

[80]  Elbert W. Russell,et al.  A multiple scoring method for the assessment of complex memory functions. , 1975 .

[81]  P. Kaniaris,et al.  Serum free fatty acid and blood sugar levels in children under halothane, thiopentone and ketamine anaesthesia (comparative study) , 1975, Canadian Anaesthetists' Society journal.

[82]  R. Biersner,et al.  Attention, Learning, and Personality During Ketamine Emergence: A Pilot Study , 1975, Anesthesia and analgesia.

[83]  J. Dundee,et al.  Plasma Cortisol and blood sugar following minor surgery under intravenous anaesthetics , 1974, Anaesthesia.

[84]  J. Overall.  The Brief Psychiatric Rating Scale in psychopharmacology research. , 1974 .

[85]  R W Farmer,et al.  Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. , 1974, Clinical chemistry.

[86]  E. Redgate,et al.  Pituitary adrenal response to ketamine and the inhibition of the response by catecholaminergic blockade. , 1974, Neuroendocrinology.

[87]  J. Dundee,et al.  CLINICAL STUDIES OF INDUCTION AGENTS XXXVII: AMNESIC ACTION OF KETAMINE , 1971, British journal of anaesthesia.

[88]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[89]  T. Kudo,et al.  Effects of Ketamine on Adrenocortical Function in Man , 1970, Anesthesia and analgesia.

[90]  Murray Sidman,et al.  Some additional quantitative observations of immediate memory in a patient with bilateral hippocampal lesions , 1968 .

[91]  E F Domino,et al.  Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581 , 1966, Anesthesia and analgesia.

[92]  G. Rosenbaum,et al.  Model psychoses and schizophrenia. , 1962, The American journal of psychiatry.

[93]  G. Rosenbaum,et al.  Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. , 1962, Archives of general psychiatry.

[94]  C. Bakker,et al.  Observations on the psychotomimetic effects of Sernyl. , 1961, Comprehensive psychiatry.

[95]  H. Beech,et al.  The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers. , 1960, The Journal of mental science.

[96]  G. Rosenbaum,et al.  Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.

[97]  M. Johnstone,et al.  Sernyl (CI-395) in clinical anaesthesia. , 1959, British journal of anaesthesia.

[98]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[99]  D. Wechsler.  A Standardized Memory Scale for Clinical Use , 1945 .

[100]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[101]  W. Couldwell.  CLINICAL STUDIES , 2022 .